StockTipsArenaBeta

BUY CREDITACCESS GRAMEEN LIMITED — Emkay Global

BUYCREDITACCESS GRAMEEN LIMITED
CREDITACCESS GRAMEEN share price target & all analyst calls

byEmkay GlobalHorizon: NA (inferred 1 year)10 May 2026via Institutional / Brokerage Research

Entry₹1,497Inferred
Target₹1,750
Total upside +16.90%
Stop lossNot given
CMP₹1,110.4Just now
Active-25.82%+57.60%upside left 7 mo left
Follow Emkay Global for new calls(64% target hit, 375 closed calls)Get alertsWatch CREDITACC for new buy/sell callsGet alertsSee 10 other Long-term calls on CREDITACCSee 190 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 9:21 am IST
17 supporting6 neutral1 opposing
Supports the BUY call (17)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·21 Oct · yesterday

CreditAccess Grameen to raise $175 million overseas loans from DBS, Standard Chartered and others

NewsEt-Markets·12 Oct · 1w ago

(opens in new tab)

CreditAccess Grameen raises $175 million through syndicated social loan facility

NewsCnbc-Tv18·12 Oct · 1w ago

(opens in new tab)

CreditAccess Grameen has secured a USD 175 million syndicated social loan facility, expanding its global lender base.

NSE · Press Release·12 Oct · 1w ago

(opens in new tab)

CreditAccess Grameen has secured a USD 175 million syndicated social loan facility as an External Commercial Borrowing, diversifying its funding sources.

BSE · Company Update·12 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (6)

Q2 FY27 results scheduled — board meets 22 Oct 2026

BSE · Board Meeting·22 Oct · today

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on CREDITACCESS GRAMEEN

All analyst calls on CREDITACCESS GRAMEEN

More from Emkay Global

Every call and its outcome